Overview


According to FutureWise analysis the market for cannabidiol oil (cbd oil) in 2023 is US$ 7.45 billion, and is expected to reach US$ 25.14 billion by 2031 at a CAGR of 16.4%.

Cannabidiol (CBD) oil is a natural extract that is derived from the cannabis plant, specifically from the hemp plant. It is a non-psychoactive substance, which means it does not cause the "high" or intoxication associated with the use of marijuana. CBD oil is becoming more popular due to its potential therapeutic benefits and uses in various medical and wellness applications. CBD oil has been proven to offer a variety of possible health advantages, including reduced anxiety and depression levels, pain and inflammation relief, and improved sleep quality. It is believed to work by interacting with the body's endocannabinoid system (ECS), which maintains homeostasis or balance in the body. CBD oil may help to regulate the ECS by modulating the activity of the cannabinoid receptors, which can help to improve various physiological functions.

Pain treatment is one of the most prevalent uses for CBD oil. It is believed to have analgesic properties, meaning it may help to reduce pain and inflammation in the body. CBD oil has been demonstrated to be effective in reducing pain in conditions such as arthritis, multiple sclerosis, and neuropathic pain. It may also help to reduce the need for opioid-based painkillers, which can be addictive and have severe side effects. CBD oil is also used for its potential anti-anxiety and anti-depressant effects. It has been proven to reduce symptoms of anxiety and depression in animal studies and clinical trials. CBD oil may help to regulate neurotransmitters such as serotonin and dopamine, which are important in regulating mood and emotional well-being.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Cannabidiol Oil (CBD Oil) Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Cannabidiol Oil (CBD Oil) Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • CVSciences, Inc.
  • Medical Marijuana, Inc.
  • CHARLOTTE’S WEB
  • ENDOCA
  • Isodiol
  • Elixinol
  • NuLeaf Naturals, LLC
  • JOY Organics
  • Kazmira
  • Lord Jones
  • Aurora Cannabis
  • Canopy Growth Corporation
  • Global Cannabinoids, Inc.
  • IrieCBD
  • CBD American Shaman.
  • BioVectrainc.
  • Bluebird Botanicals
  • Noramco
  • Cure Pharmaceutical.
  • GW Pharmaceuticals, PLC.
  • CBDepot
  • Cibdol
  • THC Pharm Gmbh

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in Cannabidiol Oil Market:

In January 2021, The U.S. Patent and Trademark Office granted Next Leaf a patent for a procedure that expands the U.S. patent portfolio and produces a solventless cannabis concentrate.

In May 2022, In order to increase access to CBD products in pharmacies, Medical Marijuana, Inc. established a pharmaceutical subsidiary, HM Pharma, in Brazil.

In recent years, the market for cannabidiol (CBD) oil has seen substantial expansion, driven by the increasing adoption of CBD products for medical and wellness purposes. CBD oil is a non-psychoactive compound derived from the hemp plant, which is known for its therapeutic properties, such as pain relief, anxiety reduction, and anti-inflammatory effects. One of the key drivers of the CBD oil market is the growing awareness among consumers about the benefits of CBD oil. As people become more health conscious, they are seeking natural alternatives to traditional pharmaceuticals, and CBD oil has emerged as a popular option. Additionally, the legalization of CBD oil in many countries and states has further boosted its demand, making it more widely available to consumers. The market is also being influenced by the increasing number of research studies on CBD oil's therapeutic effects. The positive results from these studies have helped to increase consumer confidence in the product and have encouraged more people to try it. In addition, the growing acceptance of CBD oil by the medical community has led to its inclusion in treatment plans for various medical conditions, further driving its demand. Another important factor that is driving the CBD oil market is the increasing availability of CBD products across various distribution channels. CBD oil is available in various forms, including capsules, tinctures, edibles, and topicals, and it is being sold in retail stores, online marketplaces, and through direct-to-consumer channels. This makes it easy for consumers to access and purchase CBD oil products, contributing to the market's growth.

However, despite the positive growth trends, the CBD oil market is also facing some challenges. One of the primary issues is the absence of defined regulations and guidelines governing the production and sale of CBD oil products. This has led to product quality and safety inconsistencies, making it difficult for consumers to navigate the market and make informed purchasing decisions. As a result, there is a requirement for better regulation to ensure product quality and consumer safety, which could slow down the market's growth in the short term.

By Product

  • CBD Oil
    •  CBD Oil
    •  CBD Isolate
    •  Synthetic CBD
  • CBD Consumer Health
    •   Medical OTC Products
      •    CBD Analgesic Products
      •    CBD Dermatology Products
      •   CBD Mental Health Products
      •    CBD Sleeping Aids Products
      •    Other OTC Products
    • Nutraceuticals
      •    CBD Vitamins and Dietary Supplements (VDS)
      •    CBD Sports Nutrition
      •    CBD Weight Management and Wellbeing
    •  Food and Beverages
    •  Pharmaceuticals
    •  Personal Care & Cosmetic Products
      •    CBD Infused Skin Care Products
      •    CBD Infused Beauty Products
      •  CBD Infused Hair Care Products

By Distribution Channel

  • CBD Oil
    •  B2B
      •    Pharma Manufacturers
      •    Consumer Goods Manufacturers
      •    Nutraceutical Manufacturers
      •    Others
    •  B2C
  • CBD Consumer Health
    •  Online
    •  Retail Stores
    •  Retail Pharmacies

By Region

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The North American region is predicted to have a substantial proportion of the target market due to the rising acceptability of cannabis-based products in the treatment of psychiatric illnesses and the region's expanding growth activities. Key competitors' strategic actions, such as new launches, product innovation, approvals, and alliances, support market expansion. Pure Extracts Technologies, for example, signed an agreement in January 2021 to purchase 220 kilograms of high-potency cannabis dried flower from a large Canadian licensed producer in order to scale up the production of its CBD extracts. Furthermore, various cannabis-based products have been licensed and regulated in the United States and Canada, which will play an important role in the growth of the cannabidiol (CBD) oil market throughout the projection period. Additionally, based on application; the food and beverage segment is the highest-growing segment in the global market.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the Cannabidiol Oil (CBD Oil) Market By Product, By Distribution Channel and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- Source launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Gradeology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Cannabidiol Oil (CBD Oil) Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Cannabidiol Oil (CBD Oil) Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Cannabidiol Oil (CBD Oil) Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Cannabidiol Oil (CBD Oil) Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •  1. CBD Oil
          1.1. CBD Oil
          1.2. CBD Isolate
          1.3. Synthetic CBD
       2.  CBD Consumer Health
           2.1. Medical OTC Products
               2.1.1. CBD Analgesic Products
               2.1.2.CBD Dermatology Products
               2.1.3.CBD Mental Health Products
               2.1.4.CBD Sleeping Aids Products
               2.1.5.Other OTC Products
        3. Nutraceuticals
           3.1. CBD Vitamins and Dietary Supplements (VDS)
           3.2. CBD Sports Nutrition
           3.3. CBD Weight Management and Wellbeing
        4. Food and Beverages
        5. Pharmaceuticals
        6. Personal Care & Cosmetic Products
            6.1. CBD Infused Skin Care Products
            6.2. CBD Infused Beauty Products
            6.3. CBD Infused Hair Care Products

  • 8.   Cannabidiol Oil (CBD Oil) Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •  1. CBD Oil
          1.1. B2B
              1.1.1. Pharma Manufacturers
              1.1.2. Consumer Goods Manufacturers
              1.1.3. Nutraceutical Manufacturers
              1.1.4. Others
          1.2. B2C
       2. CBD Consumer Health
          2.1. Online
          2.2. Retail Stores
          2.3. Retail Pharmacies

  • 9.   North America Cannabidiol Oil (CBD Oil) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Cannabidiol Oil (CBD Oil) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Cannabidiol Oil (CBD Oil) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Cannabidiol Oil (CBD Oil) Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Sources Offered and Financial Layouts)
    •   1. CVSciences, Inc.
         1.1. Company Overview
         1.2. Source Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medical Marijuana, Inc.
         2.1. Company Overview
         2.2. Source Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. CHARLOTTE’S WEB
         3.1. Company Overview
         3.2. Source Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. ENDOCA
         4.1. Company Overview
         4.2. Source Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Isodiol
         5.1. Company Overview
         5.2. Source Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Elixinol
         6.1. Company Overview
         6.2. Source Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. NuLeaf Naturals, LLC
         7.1. Company Overview
         7.2. Source Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. JOY Organics
         8.1. Company Overview
         8.2. Source Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Kazmira
         9.1. Company Overview
         9.2. Source Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Lord Jones
         10.1. Company Overview
         10.2. Source Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Aurora Cannabis
         11.1. Company Overview
         11.2. Technology Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Canopy Growth Corporation
         12.1. Company Overview
         12.2. Technology Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Global Cannabinoids, Inc.
         13.1. Company Overview
         13.2. Technology Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. IrieCBD
         14.1. Company Overview
         14.2. Technology Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. CBD American Shaman.
         15.1. Company Overview
         15.2. Technology Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. BioVectrainc.
         16.1. Company Overview
         16.2. Technology Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Bluebird Botanicals
         17.1. Company Overview
         17.2. Technology Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. Noramco
         18.1. Company Overview
         18.2. Technology Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Cure Pharmaceutical
         19.1. Company Overview
         19.2. Technology Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. GW Pharmaceuticals, PLC.
         20.1. Company Overview
         20.2. Technology Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. CBDepot
         21.1. Company Overview
         21.2. Technology Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. Cibdol
         22.1. Company Overview
         22.2. Technology Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
        23. THC Pharm Gmbh
         23.1. Company Overview
         23.2. Technology Portfolio
         23.3. SWOT Analysis
         23.4. Financial Overview
         23.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients